Vanguard Personalized Indexing Management’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
Vanguard Personalized Indexing Management's ONC Position: Q2 2026 in Review
Vanguard Personalized Indexing Management increased its BeOne Medicines Ltd (ONC) stake by 1.9% in Q2 2026, buying an estimated $17.4K and bringing the position to 3,240 shares worth $923K. The position accounts for 0.01% of the portfolio, ranked #1047.
Vanguard Personalized Indexing Management first reported a position in ONC in Q1 2021 and has held it in 16 quarters since. The position peaked at $993K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.
- Vanguard Personalized Indexing Management held 3,240 shares of BeOne Medicines Ltd worth $923K as of Q2 2026.
- Vanguard Personalized Indexing Management bought 59 BeOne Medicines Ltd shares in Q2 2026, an estimated $17.4K.
- BeOne Medicines Ltd made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1047 holding.
- Vanguard Personalized Indexing Management first reported a position in BeOne Medicines Ltd in Q1 2021 and has held it in 16 quarters since.
- Vanguard Personalized Indexing Management's BeOne Medicines Ltd position peaked at $993K in Q4 2025.
- 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.
Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.